查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751518

動物保健單株抗體市場規模、佔有率、趨勢分析報告：按應用、動物類型、最終用戶、地區、細分預測，2025-2030 年

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type (Dogs), By End User (Veterinary Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

動物保健單株抗體市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，全球動物保健單株抗體市場預計到 2030 年將達到 33 億美元，2025 年至 2030 年的複合年成長率為 19.1%。

寵物數量的成長以及寵物消費的增加預計將推動市場成長。此外，犬異位性皮膚炎的盛行率上升也可能在預測期內推動市場成長。

儘管新冠疫情造成了衝擊，動物用藥品產業在2019年至2020年期間仍實現了8%的穩定成長。與其他市場相比，經濟衰退對動物用藥品產業的影響相對較小。疫情也為動物醫院和獸醫的經營模式帶來了許多變化。預計傳統動物醫院的大部分收益將來自生技藥品和藥品等高利潤產品的銷售。

癌症發生率的上升，尤其是在犬類中，預計將為市場的成長奠定基礎。根據美國獸醫協會 (AVMA) 的數據，預計四分之一的犬隻在其一生中的某個階段會出現腫瘤的徵兆。腫瘤是犬類常見的一種癌症。疼痛管理是治療犬類腫瘤最重要的方面之一，單株抗體也可以治療腫瘤。

市場競爭激烈，大型企業林立。隨著市場湧現巨大的機會，各家企業紛紛加大投資，力求成為產業領導者。例如，碩騰公司於2021年10月在愛爾蘭收購了一家新的研發和生產部門，以提升其獸用單株抗體（mAb）的生產能力。

此舉預計將增強禮來在動物治療生物製藥領域的產品組合。此外，禮來於2021年8月以約4.44億美元收購了Kindred Biosciences，此舉有助於禮來進軍皮膚病學市場，補充產品平臺，並增強其在生技藥品和單株抗體領域的研發能力。

此外，Elanco於2023年5月宣布，該公司使用單株抗體研發出突破性的致命犬小病毒病治療方法。這種單次靜脈注射可治療病犬和幼犬的細小病毒症狀，無論它們是否接種過疫苗。

動物保健單株抗體市場報告重點

  • 根據動物類型，預計到 2024 年，狗類市場將佔據絕大部分收入，這歸因於人們擴大將狗作為寵物飼養，以及針對犬類疾病治療的研究和開發不斷增加。
  • 根據應用，由於犬類異位性皮膚炎盛行率不斷上升，皮膚病學領域將在 2024 年佔據最大的市場佔有率，超過 51.31%。
  • 根據最終用途，由於獸醫院擁有先進的治療設施，獸部門在 2024 年佔據了主導市場佔有率。
  • 由於該地區有大型市場公司，預計到 2024 年北美將佔據最大的市場佔有率，約 43.775%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 產業分析
    • 波特五力分析
    • 佩斯特爾
  • 法律規範
  • 產品平臺分析
  • 定價分析
  • COVID-19影響分析

第4章動物保健單株抗體市場：按動物類型估計和趨勢分析

  • 細分儀表板
  • 動物保健單株抗體市場：2024 年和 2030 年動物類型差異分析
  • 狗
  • 其他

第5章動物保健單株抗體市場：應用評估與趨勢分析

  • 細分儀表板
  • 動物保健單株抗體市場：2024 年和 2030 年應用趨勢分析
  • 皮膚科市場
  • 疼痛
  • 其他

第6章動物保健單株抗體市場：最終用戶估計和趨勢分析

  • 動物保健單株抗體市場：2024 年和 2030 年最終用戶差異分析
  • 獸醫診所
  • 其他

第7章動物保健單株抗體市場：區域估計與趨勢分析

  • 動物保健單株抗體市場：2024 年和 2030 年區域差異分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Zoetis Inc.
    • Boehringer Ingelheim Gmbh
    • Merck &Co., Inc.
    • Elanco
    • Virbac SA
    • Indian Immunologicals Ltd
  • 戰略地圖
    • 合併與收購
    • 夥伴關係和合作
    • 擴張
    • 產品發布
    • 產品核可
    • 其他
  • List of Other Players

第9章 重點

Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends:

The global monoclonal antibodies in veterinary health market size is estimated to reach USD 3.30 billion by 2030, expanding at a CAGR of 19.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights:

  • Based on animal type, the dog segment held the dominant revenue share in 2024 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 51.31% in 2024, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2024, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 43.775% in 2024, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. Pricing Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End User Movement Analysis, 2024 & 2030 (USD Million)
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Sweden Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Denmark Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Norway Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Thailand Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. UAE Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Kuwait Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Zoetis Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Boehringer Ingelheim Gmbh
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Merck & Co., Inc.
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Elanco
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Virbac S.A.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Indian Immunologicals Ltd
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Expansion
    • 8.4.4. Product launch
    • 8.4.5. Product Approval
    • 8.4.6. Others
  • 8.5. List of Other Players

Chapter 9. Key Takeaways

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global Monoclonal Antibodies In Veterinary Health Market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 5 Global Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 6 North America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 9 North America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 10 U.S. Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 13 Canada Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 15 Canada Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 16 Europe Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 19 Europe Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 22 UK Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 23 Germany Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 25 Germany Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 26 France Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 29 Italy Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 31 Italy Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 32 Spain Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 34 Spain Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 35 Denmark Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 38 Sweden Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 41 Norway Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 43 Norway Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 48 Japan Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 50 Japan Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 51 China Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 52 China Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 53 China Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 54 India Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 56 India Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 57 South Korea Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 60 Australia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 62 Australia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 63 Thailand Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 66 Latin America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 70 Brazil Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 73 Mexico Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 74 Mexico Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 76 Argentina Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 79 MEA Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 82 MEA Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 83 South Africa Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 89 UAE Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 91 UAE Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 95 Participant's overview
  • Table 96 Financial performance
  • Table 97 Indication/ Services benchmarking
  • Table 98 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Monoclonal Antibodies In Veterinary Health Market revenue, 2018-2030 (USD Million)
  • Fig. 10 Monoclonal Antibodies In Veterinary Health Market Snapshot
  • Fig. 11 Monoclonal Antibodies In Veterinary Health Market driver impact
  • Fig. 12 Monoclonal Antibodies In Veterinary Health Market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Monoclonal Antibodies In Veterinary Health Market Animal Type key takeaways (USD Million)
  • Fig. 16 Monoclonal Antibodies In Veterinary Health Market: Animal Type movement analysis
  • Fig. 17 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 18 Other animals market, 2018 - 2030 (USD Million)
  • Fig. 19 Monoclonal Antibodies In Veterinary Health Market Application key takeaways (USD Million)
  • Fig. 20 Monoclonal Antibodies In Veterinary Health Market: Application movement analysis
  • Fig. 21 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 22 Pain market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Monoclonal Antibodies In Veterinary Health Market End user key takeaways (USD Million)
  • Fig. 25 Monoclonal Antibodies In Veterinary Health Market: End user movement analysis
  • Fig. 26 Veterinary Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 27 Other end user market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 North America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 China Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 India Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 MEA Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 58 Market participant categorization
  • Fig. 59 Heat map analysis
  • Fig. 60 Strategy Mappings